1.3.1.6: fumarate reductase (NADH)
This is an abbreviated version!
For detailed information about fumarate reductase (NADH), go to the full flat file.
Word Map on EC 1.3.1.6
-
1.3.1.6
-
nitrate
-
malate
-
shewanella
-
fad
-
flavoproteins
-
fumarase
-
iron-sulfur
-
succinogenes
-
ascaris
-
flavocytochrome
-
helminth
-
oneidensis
-
wolinella
-
viologen
-
anthelmintic
-
frigidimarina
-
succinate-ubiquinone
-
tetraheme
-
menaquinol
-
narghji
-
thiabendazole
-
sdhcdab
-
c4-dicarboxylate
-
geobacter
-
flavinylation
-
succinate:quinone
-
dmsabc
-
hymenolepis
-
cyma
-
putrefaciens
-
medicine
-
drug development
- 1.3.1.6
- nitrate
- malate
- shewanella
- fad
- flavoproteins
- fumarase
-
iron-sulfur
- succinogenes
- ascaris
-
flavocytochrome
-
helminth
- oneidensis
-
wolinella
- viologen
-
anthelmintic
- frigidimarina
-
succinate-ubiquinone
-
tetraheme
- menaquinol
-
narghji
- thiabendazole
- sdhcdab
-
c4-dicarboxylate
- geobacter
-
flavinylation
-
succinate:quinone
- dmsabc
-
hymenolepis
-
cyma
- putrefaciens
- medicine
- drug development
Reaction
Synonyms
ABB37_00293, FRD, FRdABCD, FRDg, FRDm1, FRDm2, FRDS, Frds1p, fumarate reductase, KPA86010, KPK_2907, mitochondrial rhodoquinol-fumarate reductase, NADH-dependent fumarate reductase, NADH-FR, NADH-FRD, NADH-fumarate reductase, NFRD, QFR
ECTree
Advanced search results
Disease
Disease on EC 1.3.1.6 - fumarate reductase (NADH)
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Acquired Immunodeficiency Syndrome
Isocitrate Lyase and Succinate Semialdehyde Dehydrogenase Mediate the Synthesis of ?-Ketoglutarate in Pseudomonas fluorescens.
Arthritis, Rheumatoid
Selective IgA immune unresponsiveness to Proteus mirabilis fumarate reductase A-chain in rheumatoid arthritis.
Chagas Disease
Mercaptopyridine-N-oxide, an NADH-fumarate reductase inhibitor, blocks Trypanosoma cruzi growth in culture and in infected myoblasts.
Cysts
Effects of mebendazole, albendazole, and praziquantel on succinate dehydrogenase, fumarate reductase, and malate dehydrogenase in Echinococcus granulosus cysts harbored in mice.
Echinococcosis
Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis.
Gastritis, Atrophic
Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
Helminthiasis
Wortmannilactones I-L, new NADH-fumarate reductase inhibitors, induced by adding suberoylanilide hydroxamic acid to the culture medium of Talaromyces wortmannii.
Infections
A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice.
Infections
Analysis of the Actinobacillus pleuropneumoniae ArcA regulon identifies fumarate reductase as a determinant of virulence.
Infections
Characterization of genes differentially expressed within macrophages by virulent and attenuated Mycobacterium tuberculosis identifies candidate genes involved in intracellular growth.
Infections
Mycobacterium tuberculosis and M. bovis BCG Moreau Fumarate Reductase Operons Produce Different Polypeptides That May Be Related to Non-canonical Functions.
Infections
Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection.
Infections
Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR.
Neoplasms
An anticancer agent, pyrvinium pamoate inhibits the NADH-fumarate reductase system--a unique mitochondrial energy metabolism in tumour microenvironments.
Neoplasms
Mitochondrial fumarate reductase as a target of chemotherapy: From parasites to cancer cells.
Neoplasms
Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration.
Neoplasms
The NADH-fumarate reductase system, a novel mitochondrial energy metabolism, is a new target for anticancer therapy in tumor microenvironments.
Paragonimiasis
Paragonimus westermani possesses aerobic and anaerobic mitochondria in different tissues, adapting to fluctuating oxygen tension in microaerobic habitats.
Paralysis
Changes in the adenylate energy charge of Nematospiroides dubius and Trichostrongylus colubriformis paralysed by levamisole in vivo.
Trypanosomiasis, African
Efficient flavinylation of glycosomal fumarate reductase by its own ApbE domain in Trypanosoma brucei.
Tuberculosis
Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis.
Tuberculosis
Mycobacterium tuberculosis and M. bovis BCG Moreau Fumarate Reductase Operons Produce Different Polypeptides That May Be Related to Non-canonical Functions.
html completed